These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11041257)

  • 1. Application of fibroin in controlled release tablets containing theophylline.
    Katayama H; Issiki M; Yoshitomi H
    Biol Pharm Bull; 2000 Oct; 23(10):1229-34. PubMed ID: 11041257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
    Bayomi MA; Al-Suwayeh SA; El-Helw AR
    Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of curdlan to controlled drug delivery. II. In vitro and in vivo drug release studies of theophylline-containing curdlan tablets.
    Kanke M; Katayama H; Nakamura M
    Biol Pharm Bull; 1995 Aug; 18(8):1104-8. PubMed ID: 8535404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release.
    Faham A; Prinderre P; Farah N; Eichler KD; Kalantzis G; Joachim J
    Drug Dev Ind Pharm; 2000 Feb; 26(2):167-76. PubMed ID: 10697753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro conditions for the study of the in vivo performance of sustained-release theophylline matrix tablets administered in fasted conditions and with a high-fat diet.
    Andonaegui MT; Barría JL; Thielemann AM; Seitz C; Gai MN
    Drug Dev Ind Pharm; 1999 Nov; 25(11):1199-203. PubMed ID: 10596358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation in dogs of theophylline in a novel zero-order release core-in-cup tablet.
    Danckwerts MP; van der Watt JG; Moodley I
    Biopharm Drug Dispos; 1998 Nov; 19(8):517-22. PubMed ID: 9840213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of diluent on the release of theophylline from hydrophilic matrix tablets.
    Pina ME; Veiga F
    Drug Dev Ind Pharm; 2000 Oct; 26(10):1125-8. PubMed ID: 11028230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new drug delivery system using plasma-irradiated pharmaceutical aids. V. Controlled release of theophylline from plasma-irradiated double-compressed tablet composed of a wall material containing polybenzylmethacrylate.
    Ishikawa M; Noguchi T; Niwa J; Kuzuya M
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2215-20. PubMed ID: 8582024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of food-induced changes in the absorption of theophylline from Uniphyl tablets.
    Arkinstall WW; Hopkinson M; Rivington RN; Calcutt L; Aitken T; Stewart JH
    J Allergy Clin Immunol; 1988 Aug; 82(2):155-64. PubMed ID: 3273483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
    Raj NS; Guleria R; Misra A; Pande JN
    Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
    Hussein Z; Friedman M
    Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled porosity osmotic pump system with biphasic release of theophylline: influence of weight gain on its in vivo pharmacokinetics.
    Bi Y; Zhang Y; Zhao J; Mao S; Hou S
    Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):792-5. PubMed ID: 18520082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of theophylline. III. Premarketing study for a once-daily administered preparation.
    Tanigawara Y; Komada F; Shimizu T; Iwakawa S; Iwai T; Maekawa H; Hori R; Okumura K
    Biol Pharm Bull; 1995 Nov; 18(11):1590-8. PubMed ID: 8593486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of colon degradation of polysaccharide on the oral bioavailability of theophylline from controlled release hydrophilic matrices.
    Babu GV; Himasankar K; Kumar NR; Murty KV
    Boll Chim Farm; 2003 Dec; 142(10):454-60. PubMed ID: 14971315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo drug release from hydrophilic dextran tablets capable of forming polyion complex.
    Miyazaki Y; Tanaka Y; Yakou S; Takayama K
    J Control Release; 2006 Aug; 114(1):47-52. PubMed ID: 16824636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.